How to use ACE-inhibitors, beta-blockers, and newer therapies in AMI. (Q33699894)

28 July 2017

1 reference

title

How to use ACE-inhibitors, beta-blockers, and newer therapies in AMI. (English)

1 reference

28 July 2017

Maggioni AP

1

1 reference

28 July 2017

Latini R

series ordinal

2

1 reference

28 July 2017

language of work or name

English

0 references

publication date

1 August 1999

1 reference

28 July 2017

published in

American Heart Journal

1 reference

28 July 2017

volume

138

1 reference

28 July 2017

issue

2 Pt 2

1 reference

28 July 2017

page(s)

S183-7

1 reference

Beta blockade during and after myocardial infarction: an overview of the randomized trials

28 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970341-8

Beta blockade early in acute myocardial infarction.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970341-8

Cardiac rupture, mortality and the timing of thrombolytic therapy: a meta-analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970341-8

Immediate versus deferred beta-blockade following thrombolytic therapy in patients with acute myocardial infarction. Results of the Thrombolysis in Myocardial Infarction (TIMI) II-B Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970341-8

Timolol-induced reduction in mortality and reinfarction in patients surviving acute myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970341-8

A randomized trial of propranolol in patients with acute myocardial infarction. I. Mortality results

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970341-8

Effect on mortality of metoprolol in acute myocardial infarction. A double-blind randomised trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970341-8

Treatment of myocardial infarction in the United States (1990 to 1993). Observations from the National Registry of Myocardial Infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970341-8

Renin-angiotensin system inhibition in acute myocardial infarction in dogs. Effects on systemic hemodynamics, myocardial blood flow, segmental myocardial function and infarct size

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970341-8

Limitation of experimental infarct size by an angiotensin-converting enzyme inhibitor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970341-8

Effects of the early administration of enalapril on mortality in patients with acute myocardial infarction. Results of the Cooperative New Scandinavian Enalapril Survival Study II (CONSENSUS II)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970341-8

Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970341-8

A clinical trial of the angiotensin-converting-enzyme inhibitor trandolapril in patients with left ventricular dysfunction after myocardial infarction. Trandolapril Cardiac Evaluation (TRACE) Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970341-8

Captopril-induced changes in prostaglandin production: relationship to vascular responses in normal man

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970341-8

Counteraction of the vasodilator effects of enalapril by aspirin in severe heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970341-8

Combining salicylate and enalapril in patients with coronary artery disease and heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970341-8

ACE inhibitor use in patients with myocardial infarction. Summary of evidence from clinical trials.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970341-8

Randomised trial of losartan versus captopril in patients over 65 with heart failure (Evaluation of Losartan in the Elderly Study, ELITE)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970341-8

Sex differences in myocardial infarction and coronary deaths in the Scottish MONICA population of Glasgow 1985 to 1991. Presentation, diagnosis, treatment, and 28-day case fatality of 3991 events in men and 1551 events in women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970341-8

Indications for ACE inhibitors in the early treatment of acute myocardial infarction: systematic overview of individual data from 100,000 patients in randomized trials. ACE Inhibitor Myocardial Infarction Collaborative Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970341-8

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0002-8703(99)70341-8

1 reference

28 July 2017

1 reference